CLINICAL_TRIALS
trial_result
· 2025-03-24
Clinical Trial Update: (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist [Phase 4]
Summary
Phase 4 trial evaluating onabotulinumtoxinA (Botox) for migraine to understand its mechanism of action on the molecular environment around pain fibers. The stud…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2025-03-24